H1 partners with Novo Nordisk to build AI-driven data foundation for clinical development

Clinical trials are becoming more complex and data‑heavy, but decision‑making processes have not kept pace.

H1 and Novo Nordisk are collaborating to address this gap. Novo Nordisk’s StudyHub links workflows across study design, country allocation, site selection, budgeting and execution, and is already used by over 1,500 regular users across seven digital products.

H1 will add its healthcare data, technology and AI capabilities to the existing foundation, aiming to make study decisions more connected, reduce costs, speed enrollment and lower patient burden.

The partnership focuses on improving the flow of contextual information between teams, moving away from fragmented spreadsheets and meetings toward a unified data platform.